Andersson B, Caidahl K, Waagstein F
Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska Sjukhuset, Goteborg University, Sweden.
Eur Heart J. 1995 Jan;16(1):53-60. doi: 10.1093/eurheartj/16.1.53.
Idiopathic dilated cardiomyopathy (IDCM) is an exclusion diagnosis. Although it is a prognostically important entity and a common indication for cardiac transplantation, the incidence and age distribution of idiopathic IDCM in a well-defined population today is unknown. The present study intended to estimate the proportion of IDCM among congestive heart failure (CHF) patients, and to evaluate its prognostic implications. The records of all 16-65-year-old patients hospitalized for CHF or IDCM during a 6-year period (n = 2711) were evaluated in a defined region of Western Sweden (1.05 million inhabitants 16-65 years of age). Twenty-two percent (584/2711) of these records contained no plausible cause of CHF or IDCM, and among living patients an obvious aetiology was lacking in 27% (411/1516). These 411 patients were subsequently offered a diagnostic investigation including echocardiography, and were compared to a randomly selected healthy control group (n = 103). Of 411 patients, 293 accepted the investigation and 286 had acceptable echocardiographic recordings, indicating left ventricular dilatation and systolic dysfunction in 30%. From the hospital records, 170 patients were identified as new cases of IDCM during the 6-year period. Adding another 34 cases revealed by our diagnostic procedures yielded an age-gender standardized incidence rate of 29.2 cases per 10(6) persons/year. The incidence of IDCM increased considerably with age, although in younger patients its relative contribution to heart failure was greater. The incidence of IDCM was higher in the urban compared to the rural parts of the region 21 vs 32/10(6); P = 0.013). The estimated prevalence was 131/10(6).(ABSTRACT TRUNCATED AT 250 WORDS)
特发性扩张型心肌病(IDCM)是一种排除性诊断。尽管它是一个预后重要的疾病实体且是心脏移植的常见适应证,但目前在一个明确界定的人群中特发性IDCM的发病率和年龄分布尚不清楚。本研究旨在估计充血性心力衰竭(CHF)患者中IDCM的比例,并评估其预后意义。在瑞典西部一个特定区域(16至65岁居民105万),对6年间因CHF或IDCM住院的所有16至65岁患者(n = 2711)的记录进行了评估。这些记录中有22%(584/2711)未包含CHF或IDCM的合理病因,在存活患者中,27%(411/1516)缺乏明显病因。随后为这411例患者提供了包括超声心动图在内的诊断检查,并与随机选择的健康对照组(n = 103)进行比较。411例患者中,293例接受了检查,286例有可接受的超声心动图记录,其中30%显示左心室扩张和收缩功能障碍。从医院记录中,在6年期间确定了170例IDCM新病例。加上我们诊断程序发现的另外34例,年龄-性别标准化发病率为每10(6)人/年29.2例。IDCM的发病率随年龄显著增加,尽管在年轻患者中其对心力衰竭的相对贡献更大。该区域城市地区IDCM的发病率高于农村地区(分别为21/10(6)和32/10(6);P = 0.013)。估计患病率为131/10(6)。(摘要截断于250字)